Valneva
Valneva Logo
About Valneva
Valneva SE is a specialty vaccine company focused on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with unmet medical needs. Its product portfolio includes IXIARO for Japanese encephalitis, DUKORAL for cholera and ETEC, IXCHIQ for chikungunya, and VLA2001 for COVID-19. Valneva also advances vaccine candidates targeting Lyme disease, chikungunya, human metapneumovirus, and Epstein-Barr virus. The company serves customers worldwide and collaborates with partners to co-develop and commercialize innovative vaccines.
Address
6 rue Alain Bombard,
Saint-Herblain, 44800
France
Year founded
1999
Number of employees
600-700
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
